IL-1β maintains the redox balance by regulating glutaredoxin 1 expression during oral carcinogenesis

Journal of Oral Pathology and Medicine

Volumn 46, Issue 5, 2017, Pages 332-339

  Chen, Xijuan ^a,b   Lv, Qianshu ^b   Hong, Yun ^a,b   Chen, Xiaobing ^a,b   Cheng, Bin ^a,b   Wu, Tong ^a,b  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Grx1; IL 1 ; oral squamous cell carcinoma; reactive oxygen species; redox balance

Indexed keywords

GLUTAREDOXIN; GLUTAREDOXIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; LEUKOPLAKIA; MALE; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TUMOR MICROENVIRONMENT; UPREGULATION; ANIMAL; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; METABOLISM; MOUTH TUMOR; OXIDATION REDUCTION REACTION; SPRAGUE DAWLEY RAT; SQUAMOUS CELL CARCINOMA;

ANIMALS; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAREDOXINS; HUMANS; INTERLEUKIN-1BETA; MALE; MOUTH NEOPLASMS; OXIDATION-REDUCTION; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES;

EID: 84991457521     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12502     Document Type: Article

References (15)

1. Dinarello CA. Why not treat human cancer with interleukin-1 blockade? Cancer Metastasis Rev 2010; 29: 317–29.
2. Wu T, Hong Y, Jia L, et al. Modulation of IL-1βreprogrammes the tumor microenvironment to interrupt oral carcinogenesis. Sci Rep 2016; 6: 20208.
3. Allen EMG, Mieyal JJ. Protein-thiol oxidation and cell death: regulatory role of glutaredoxins. Antioxid Redox Signal 2012; 17: 1748–63.
4. Harris IS, Treloar AE, Inoue S, et al. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 2015; 27: 211–22.
5. Harris IS, Brugge JS. Cancer: the enemy of my enemy is my friend. Nature 2015; 527: 170–1.
6. Tong L, Chuang C, Wu S, et al. Reactive oxygen species in redox cancer therapy. Cancer Lett 2015; 367: 18–25.
7. Jung K, Lee JH, Thien Quach CH, et al. Resveratrol suppresses cancer cell glucose uptake by targeting reactive oxygen species-mediated hypoxia-inducible factor-1 alpha activation. J Nucl Med 2013; 54: 2161–7.
8. Stroher E, Millar AH. The biological roles of glutaredoxins. Biochem J 2012; 446: 333–48.
9. Trachootham D, Alexandre J, Huang P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discovery 2009; 8: 579–91.
10. Sung HJ, Ma W, Starost MF, et al. Ambient oxygen promotes tumorigenesis. PLoS ONE 2011; 6: e19785.
11. Sena LA, Chandel NS. Physiological roles of mitochondrial reactive oxygen species. Mol Cell 2012; 48: 158–67.
12. Trachootham D, Lu W, Ogasawara MA, et al. Redox regulation of cell survival. Antioxid Redox Signal 2008; 10: 1343–74.
13. Kozuki Y, Miura Y, Yagasaki K. Inhibitory effects of carotenoids on the invasion of rat ascites hepatoma cells in culture. Cancer Lett 2000; 151: 111–5.
14. Miura Y, Kozuki Y, Yagasaki K. Potentiation of invasive activity of hepatoma cells by reactive oxygen species is mediated by autocrine/paracrine loop of hepatocyte growth factor. Biochem Biophys Res Commun 2003; 305: 160–5.
15. Woo H, Bae CH, Song S, et al. Expression of glutaredoxin-1 in nasal polyps and airway epithelial cells. Am J Rhinol Allergy 2009; 23: 288–93.